These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17615060)

  • 21. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
    Fudala PJ; Bridge TP; Herbert S; Williford WO; Chiang CN; Jones K; Collins J; Raisch D; Casadonte P; Goldsmith RJ; Ling W; Malkerneker U; McNicholas L; Renner J; Stine S; Tusel D;
    N Engl J Med; 2003 Sep; 349(10):949-58. PubMed ID: 12954743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding Buprenorphine Use in Primary Care: Changing the Culture.
    Leiser A; Robles M
    Perm J; 2022 Jun; 26(2):177-180. PubMed ID: 35933665
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapies in early development for the treatment of opiate addiction.
    Rodríguez-Arias M; Aguilar MA; Miñarro J
    Expert Opin Investig Drugs; 2015; 24(11):1459-72. PubMed ID: 26414784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
    Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B
    Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model.
    Hasanović M; Pajević I; Kuldija A; Delić A
    Psychiatr Danub; 2012 Oct; 24 Suppl 3():S398-404. PubMed ID: 23114824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network.
    Lépine B; Debin M; Dassieu L; Gimenez L; Palmaro A; Ponté C; Swital M; Lapeyre-Mestre M; Blanchon T; Dupouy J
    J Subst Abuse Treat; 2022 Dec; 143():108891. PubMed ID: 36215914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
    Wachman EM; Saia K; Miller M; Valle E; Shrestha H; Carter G; Werler M; Jones H
    Clin Ther; 2019 Sep; 41(9):1681-1689. PubMed ID: 31358302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study.
    Iheanacho T; Payne K; Tsai J
    Am J Addict; 2020 Nov; 29(6):485-491. PubMed ID: 32367557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of addiction related immunosuppression.
    Reece AS
    J Infect; 2008 Jun; 56(6):437-45. PubMed ID: 18440646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants.
    Hall OT; Entrup P; Farabee K; Qin H; Rizvi H; Rausch J; Felkel WC; Teater J
    Subst Use Misuse; 2024; 59(2):312-315. PubMed ID: 37861246
    [No Abstract]   [Full Text] [Related]  

  • 32. Addiction in the family: Two Indigenous families overcoming barriers to opioid agonist therapy.
    Lawford K; Newman A
    Can Fam Physician; 2022 May; 68(5):348-351. PubMed ID: 35552202
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment.
    Binder P; Messaadi N; Perault-Pochat MC; Gagey S; Brabant Y; Ingrand P
    J Addict Dis; 2016; 35(2):101-8. PubMed ID: 26745033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
    Jaffe JH; O'Keeffe C
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S3-11. PubMed ID: 12738346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome.
    Malinoff HL; Barkin RL; Wilson G
    Am J Ther; 2005; 12(5):379-84. PubMed ID: 16148422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance.
    Shi JM; Henry SP; Dwy SL; Orazietti SA; Carroll KM
    Subst Abus; 2019; 40(2):132-135. PubMed ID: 30714880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.